Interactions of herpes simplex virus type 1 with ND10 and recruitment of PML to replication compartments

被引:59
作者
Burkham, J
Coen, DM
Hwang, CBC
Weller, SK
机构
[1] Univ Connecticut, Ctr Hlth, Dept Microbiol, Farmington, CT 06030 USA
[2] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA
[3] SUNY Syracuse, Upstate Med Univ, Syracuse, NY 13210 USA
关键词
D O I
10.1128/JVI.75.5.2353-2367.2001
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Many of the events required for productive herpes simplex virus type 1 (HSV-1) infection occur within globular nuclear domains called replication compartments, whose formation appears to depend on interactions with cellular nuclear domains 10 (ND10), We have previously demonstrated that the formation of HSV-1 replication compartments involves progression through several stages, including the disruption of intact ND10 (stage I to stage II) and the formation of PML-associated prereplicative sites (stage III) and replication compartments (stage IV) (J. Burkham, D. M. Coen, and S. K. Weller, J. Virol. 72:10100-10107, 1998). In this paper, we show that some, but not all, PML isoforms are recruited to stage III foci and replication compartments. Genetic experiments showed that the recruitment of PML isoforms to stage III prereplicative sites and replication compartments requires the localization of the HSV-1 polymerase protein (UL30) to these foci but does not require polymerase catalytic activity. We also examined the stages of viral infection under conditions affecting ND10 integrity. Treatment with factors that increase the stability of ND10, arsenic trioxide and the proteasome inhibitor MG132, inhibited viral disruption of ND10, formation of replication compartments, and production of progeny virus. These results strengthen the previously described correlation between ND10 disruption and productive viral infection.
引用
收藏
页码:2353 / 2367
页数:15
相关论文
共 77 条
  • [1] The promyelocytic leukemia gene product (PML) forms stable complexes with the retinoblastoma protein
    Alcalay, M
    Tomassoni, L
    Colombo, E
    Stoldt, S
    Grignani, F
    Fagioli, M
    Szekely, L
    Helin, K
    Pelicci, PG
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1998, 18 (02) : 1084 - 1093
  • [2] The PML and PML/RAR alpha domains: From autoimmunity to molecular oncology and from retinoic acid to arsenic
    Andre, C
    Guillemin, MC
    Zhu, J
    Koken, MHM
    Quignon, F
    Herve, L
    ChelbiAlix, MK
    Dhumeaux, D
    Wang, ZY
    Degos, L
    Chen, Z
    deThe, H
    [J]. EXPERIMENTAL CELL RESEARCH, 1996, 229 (02) : 253 - 260
  • [3] Polymerases and the replisome: Machines within machines
    Baker, TA
    Bell, SP
    [J]. CELL, 1998, 92 (03) : 295 - 305
  • [4] Berezney R, 1991, Semin Cell Biol, V2, P103
  • [5] CLINICAL EFFECTS AND INVITRO STUDIES OF TRIFLUOROTHYMIDINE COMBINED WITH INTERFERON-ALPHA FOR TREATMENT OF DRUG-RESISTANT AND DRUG-SENSITIVE HERPES-SIMPLEX VIRUS-INFECTIONS
    BIRCH, CJ
    TYSSEN, DP
    TACHEDJIAN, G
    DOHERTY, R
    HAYES, K
    MIJCH, A
    LUCAS, CR
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1992, 166 (01) : 108 - 112
  • [6] Promyelocytic leukemia (PML) nuclear bodies are protein structures that do not accumulate RNA
    Boisvert, FM
    Hendzel, MJ
    Bazett-Jones, DP
    [J]. JOURNAL OF CELL BIOLOGY, 2000, 148 (02) : 283 - 292
  • [7] Cross-reactivity of the anti-PML antibody PG-M3 with the herpes simplex virus type 1 immediate early protein ICP4
    Boulware, SL
    Weber, PC
    [J]. JOURNAL OF GENERAL VIROLOGY, 2000, 81 : 1773 - 1777
  • [8] ND10 protein PML is recruited to herpes simplex virus type 1 prereplicative sites and replication compartments in the presence of viral DNA polymerase
    Burkham, J
    Coen, DM
    Weller, SK
    [J]. JOURNAL OF VIROLOGY, 1998, 72 (12) : 10100 - 10107
  • [9] Cell-cycle regulation of DNA damage-induced expression of the suppressor gene PML
    Chan, JYH
    Li, L
    Fan, YH
    Mu, ZM
    Zhang, WW
    Chang, KS
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 240 (03) : 640 - 646
  • [10] Resistance to virus infection conferred by the interferon-induced promyelocytic leukemia protein
    Chelbi-Alix, MK
    Quignon, F
    Pelicano, L
    Koken, MHM
    De Thé, H
    [J]. JOURNAL OF VIROLOGY, 1998, 72 (02) : 1043 - 1051